Agilent Technologies (NYSE:A) Stock Price Breaks Below 50 Day Moving Average – Should You Sell?

Agilent Technologies, Inc. (NYSE:A – Get Free Report)’s share price crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $171.13 and traded as low as $169.40. Agilent Technologies shares last traded at $170.0980, with a volume of 1,882,239 shares trading hands.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on A. TD Cowen upped their price objective on Agilent Technologies from $180.00 to $196.00 and gave the company a “buy” rating in a research note on Tuesday, October 13th. Bank of America increased their target price on shares of Agilent Technologies from $180.00 to $190.00 in a report on Friday, October 9th. Barclays raised their price target on shares of Agilent Technologies from $175.00 to $195.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. Morgan Stanley lifted their price target on shares of Agilent Technologies from $175.00 to $190.00 and gave the company an “overweight” rating in a report on Tuesday, October 13th. Finally, Deutsche Bank initiated coverage on shares of Agilent Technologies in a research report on Monday, October 26th. They set a “buy” rating and a $190.00 price objective for the company. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $181.45.

View Our Latest Analysis on A

Agilent Technologies Price Performance

The stock’s fifty day moving average price is $171.13 and its 200-day moving average price is $139.19. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The firm has a market cap of $47.96 billion, a price-to-earnings ratio of 33.48, a price-to-earnings-growth ratio of 2.50 and a beta of 1.24.

Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same period in the previous year, the company posted $1.37 EPS. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 6.20 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 27th. Stockholders of record on Tuesday, January 5th will be issued a dividend of $0.2625 per share. The ex-dividend date is Tuesday, January 5th. This represents a $1.05 dividend on an annualized basis and a dividend yield of 0.6%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.2550. Agilent Technologies’s payout ratio is 20.67%.

Insider Activity

In other news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director owned 4,924 shares in the company, valued at approximately $745,395.12. This represents a 11.41% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.17% of the company’s stock.

Hedge Funds Weigh In On Agilent Technologies

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Investment Research Partners LLC lifted its position in shares of Agilent Technologies by 1.8% during the 3rd quarter. Investment Research Partners LLC now owns 3,646 shares of the medical research company’s stock worth $628,000 after purchasing an additional 63 shares during the last quarter. Greenleaf Trust increased its position in Agilent Technologies by 0.8% during the second quarter. Greenleaf Trust now owns 8,117 shares of the medical research company’s stock worth $1,078,000 after acquiring an additional 68 shares during the period. Plan A Wealth LLC boosted its holdings in Agilent Technologies by 1.9% in the 3rd quarter. Plan A Wealth LLC now owns 3,567 shares of the medical research company’s stock valued at $615,000 after purchasing an additional 68 shares during the period. Nilsine Partners LLC increased its holdings in shares of Agilent Technologies by 0.8% during the 2nd quarter. Nilsine Partners LLC now owns 9,650 shares of the medical research company’s stock worth $1,282,000 after purchasing an additional 72 shares during the period. Finally, Aspiriant LLC lifted its position in shares of Agilent Technologies by 2.0% in the 3rd quarter. Aspiriant LLC now owns 3,786 shares of the medical research company’s stock worth $652,000 after acquiring an additional 73 shares during the period. Institutional investors and hedge funds own 87.41% of the company’s stock.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Featured Stories

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.